I've thought Acrux was undervalued for some time.
I bought at $1.27 in August last year when the KV deal was announced, only to see the share price plummet. And now it's climbed back up again following apparently bad news - slow Evamist sales and KV backing out of development of the other six products.
The dramatic share price rise on moderate volumes suggests someone is keen to buy a large stake quickly. Which could be based on suspicion of a takeover or other news, but could also just be a value investment.
The breadth, length and speed of Acrux's product pipeline are what attract me. There seems like little long-term downside and many possibilities for very large upsides.
I'm tempted to rebalance a little from Acrux into Alchemia (my other large biotech holding), but will wait while the share price is on its current trajectory.
- Forums
- ASX - By Stock
- going strong.
I've thought Acrux was undervalued for some time. I bought at...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
-0.005(7.46%) |
Mkt cap ! $18.02M |
Open | High | Low | Value | Volume |
6.5¢ | 6.5¢ | 6.0¢ | $19.14K | 308.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 71240 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 71240 | 0.062 |
1 | 8000 | 0.061 |
3 | 319215 | 0.060 |
1 | 17200 | 0.058 |
1 | 92500 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 10000 | 1 |
0.068 | 40997 | 1 |
0.069 | 6146 | 1 |
0.070 | 76714 | 1 |
0.072 | 30000 | 1 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online